PHIO PHARMACEUTICALS CORP (PHIO)

US71880W4024 - Common Stock

0.7324  -0.07 (-8.45%)

After market: 0.79 +0.06 (+7.86%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash Equivalents
8.49M11.78M24.06M14.24M6.93M
Marketable Securities
N/AN/AN/AN/AN/A
Other Current Assets
832.00K670.00K670.00K920.00K370.00K
Total Current Assets
9.32M12.45M24.73M15.16M7.30M
 
Non-Current Assets
PPE Net
39.00K340.00K420.00K560.00K720.00K
Other Non-Current Assets
3.00K20.00K30.00K20.00K20.00K
Total Non-Current Assets
42.00K360.00K440.00K580.00K740.00K
 
TOTAL ASSETS
9.36M12.81M25.17M15.74M8.04M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
977.00K1.16M2.79M1.47M1.07M
Accounts Payable
657.00K780.00K280.00K730.00K810.00K
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
1.63M1.94M3.07M2.20M1.88M
 
Non-Current Liabilities
Long Term Debt
0.000.000.00230.00K0.00
Other Non-Current Liabilities
0.0030.00K170.00K300.00K410.00K
Total Non-Current Liabilities
0.0030.00K170.00K520.00K410.00K
 
TOTAL LIABILITIES
1.63M1.97M3.24M2.72M2.29M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-139.21M-128.38M-116.90M-103.61M-94.82M
Additional Paid In Capital
146.94M139.22M138.83M116.63M100.57M
Common Shares
370.000.000.000.000.00
Other Shareholders' Equity
-370.00N/AN/AN/AN/A
Shares Outstanding
3.75M1.14M1.13M480.00K60.00K
Tangible Book Value per Share
2.069.5119.4127.1395.83
Total Shareholders' Equity
7.73M10.84M21.93M13.02M5.75M
 
TOTAL LIABILITIES AND EQUITY
9.36M12.81M25.17M15.74M8.04M
 
Statistics
Debt/Equity
N/AN/AN/A0.02N/A
Current Ratio
5.716.428.066.893.88
Return On Assets (ROA)
-115.61%-89.62%-52.80%-55.84%-110.82%
Return On Equity (ROE)
-140.05%-105.90%-60.60%-67.51%-154.96%

All data in USD

Charts